Impact of structured personal on-site patient education on low posaconazole plasma concentrations in patients with haematological malignancies

被引:23
作者
Hoenigl, Martin [1 ,2 ]
Duettmann, Wiebke [1 ,3 ]
Raggam, Reinhard B. [4 ]
Huber-Krassnitzer, Bianca [3 ]
Theiler, Georg [3 ]
Seeber, Katharina [1 ]
Prueller, Florian [4 ]
Zollner-Schwetz, Ines [1 ]
Prattes, Juergen [1 ]
Wagner, Jasmin [1 ]
Woelfler, Albert [3 ]
Krause, Robert [2 ]
机构
[1] Med Univ Graz, Dept Internal Med, Sect Infect Dis & Trop Med, A-8036 Graz, Austria
[2] Med Univ Graz, Dept Internal Med, Div Pulmonol, A-8036 Graz, Austria
[3] Med Univ Graz, Dept Internal Med, Div Hematol, A-8036 Graz, Austria
[4] Med Univ Hosp Graz, Clin Inst Med & Chem Lab Diagnost, Graz, Austria
关键词
Posaconazole; Therapeutic drug monitoring; Plasma concentrations; Haematological malignancy; Prophylaxis; Patient education; INVASIVE FUNGAL-INFECTIONS; ACUTE MYELOID-LEUKEMIA; ANTIFUNGAL PROPHYLAXIS; ORAL POSACONAZOLE; PHARMACOKINETICS; DRUG; ASPERGILLOSIS; FLUCONAZOLE; THERAPY; SINGLE;
D O I
10.1016/j.ijantimicag.2014.03.013
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Low posaconazole plasma concentrations (PPCs) are associated with breakthrough invasive mould infections among patients with haematological malignancies. This study evaluated the influence of structured personal on-site patient education on low PPCs. The study was conducted from July 2012 to May 2013 at the Division of Hematology, Medical University Hospital of Graz (Graz, Austria). PPCs were measured in all patients with haematological malignancies receiving the drug prophylactically. Concentrations above the target of 0.5 mg/L were defined as satisfactory and those below this concentration as low. In patients with low PPCs, structured personal on-site education regarding the intake of posaconazole (e.g. intake with fatty/acid food, prevention of nausea and vomiting) was performed. In total, 258 steady-state PPCs were measured in 65 patients [median PPC 0.59 mg/L, interquartile range 0.25-0.92 mg/L; 1411258 (54.7%) satisfactory]. Diarrhoea was the strongest predictor of low PPCs in the multivariate analysis. Initial steady-state PPCs were sufficient in 29 patients and low in 36 patients. Of the 36 patients with low initial steady-state PPCs, 8 were either discharged or antifungal therapy was modified before a follow-up PPC was obtained; in the remaining 28 patients, personal on-site education was performed. In 12128 patients (43%) the personal on-site education led to sufficient levels, whilst in 16 (57%) PPCs stayed below the target, although increasing from <0.2 mg/L to >0.3 mg/L in 6 of these patients. In conclusion, personal education appears to be a promising tool to increase low PPCs. (C) 2014 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:140 / 144
页数:5
相关论文
共 29 条
[1]   Antifungal Therapeutic Drug Monitoring: Established and Emerging Indications [J].
Andes, David ;
Pascual, Andres ;
Marchetti, Oscar .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (01) :24-34
[2]   Concentration of Antifungal Agents within Host Cell Membranes: a New Paradigm Governing the Efficacy of Prophylaxis [J].
Campoli, P. ;
Al Abdallah, Q. ;
Robitaille, R. ;
Solis, N. V. ;
Fielhaber, J. A. ;
Kristof, A. S. ;
Laverdiere, M. ;
Filler, S. G. ;
Sheppard, D. C. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (12) :5732-5739
[3]   Antifungal Prophylaxis with Posaconazole in Patients with Acute Myeloid Leukemia: Dose Intensification Coupled with Avoidance of Proton Pump Inhibitors Is Beneficial in Shortening Time to Effective Concentrations [J].
Cojutti, Piergiorgio ;
Candoni, Anna ;
Simeone, Erica ;
Franceschi, Loretta ;
Fanin, Renato ;
Pea, Federico .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (12) :6081-6084
[4]   Intrapulmonary Pharmacokinetics and Pharmacodynamics of Posaconazole at Steady State in Healthy Subjects [J].
Conte, John E., Jr. ;
Golden, Jeffrey A. ;
Krishna, Gopal ;
McIver, Marina ;
Little, Emily ;
Zurlinden, Elisabeth .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (02) :703-707
[5]   Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia [J].
Cornely, Oliver A. ;
Maertens, Johan ;
Winston, Drew J. ;
Perfect, John ;
Ullmann, Andrew J. ;
Walsh, Thomas J. ;
Helfgott, David ;
Holowiecki, Jerzy ;
Stockelberg, Dick ;
Goh, Yeow-Tee ;
Petrini, Mario ;
Hardalo, Cathy ;
Suresh, Ramachandran ;
Angulo-Gonzalez, David .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (04) :348-359
[6]   Pharmacokinetics of Different Dosing Strategies of Oral Posaconazole in Patients with Compromised Gastrointestinal Function and Who Are at High Risk for Invasive Fungal Infection [J].
Cornely, Oliver A. ;
Helfgott, David ;
Langston, Amelia ;
Heinz, Werner ;
Vehreschild, Joerg-Janne ;
Vehreschild, Maria J. G. T. ;
Krishna, Gopal ;
Ma, Lei ;
Huyck, Susan ;
McCarthy, Michael C. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (05) :2652-2658
[7]   Pharmacokinetics of posaconazole coadministered with antacid in fasting or nonfasting healthy men [J].
Courtney, R ;
Radwanski, E ;
Lim, J ;
Laughlin, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (03) :804-808
[8]   Pharmacokinetics, safety, and tolerability of oral posaconazole administered in single and multiple doses in healthy adults [J].
Courtney, R ;
Pai, S ;
Laughlin, M ;
Lim, J ;
Batra, V .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (09) :2788-2795
[9]   Multicenter Study of Posaconazole Therapeutic Drug Monitoring: Exposure-Response Relationship and Factors Affecting Concentration [J].
Dolton, Michael J. ;
Ray, John E. ;
Chen, Sharon C. -A. ;
Ng, Kingsley ;
Pont, Lisa ;
McLachlan, Andrew J. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (11) :5503-5510
[10]   Oral bioavailability of posaconazole in fasted healthy subjects - Comparison between three regimens and basis for clinical dosage recommendations [J].
Ezzet, F ;
Wexler, D ;
Courtney, R ;
Krishna, G ;
Lim, J ;
Laughlin, M .
CLINICAL PHARMACOKINETICS, 2005, 44 (02) :211-220